These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31965805)

  • 1. Lipid Profiling of Serum and Lipoprotein Fractions in Response to Pitavastatin Using an Animal Model of Familial Hypercholesterolemia.
    Takeda H; Izumi Y; Tamura S; Koike T; Koike Y; Shiomi M; Bamba T
    J Proteome Res; 2020 Mar; 19(3):1100-1108. PubMed ID: 31965805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipidomic analysis of plasma lipoprotein fractions in myocardial infarction-prone rabbits.
    Takeda H; Koike T; Izumi Y; Yamada T; Yoshida M; Shiomi M; Fukusaki E; Bamba T
    J Biosci Bioeng; 2015 Oct; 120(4):476-82. PubMed ID: 26162515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ameliorating effects of D-47, a newly developed compound, on lipid metabolism in an animal model of familial hypercholesterolemia (WHHLMI rabbits).
    Tamura S; Koike Y; Takeda H; Koike T; Izumi Y; Nagasaka R; Tsunoda T; Tori M; Ogawa K; Bamba T; Shiomi M
    Eur J Pharmacol; 2018 Mar; 822():147-153. PubMed ID: 29355561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of the WHHL rabbit, an animal model of familial hypercholesterolemia, to elucidation of the anti-atherosclerotic effects of statins.
    Shiomi M; Koike T; Ito T
    Atherosclerosis; 2013 Nov; 231(1):39-47. PubMed ID: 24125408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The History of the WHHL Rabbit, an Animal Model of Familial Hypercholesterolemia (I) - Contribution to the Elucidation of the Pathophysiology of Human Hypercholesterolemia and Coronary Heart Disease.
    Shiomi M
    J Atheroscler Thromb; 2020 Feb; 27(2):105-118. PubMed ID: 31748469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plaque-stabilizing effect of pitavastatin in Watanabe heritable hyperlipidemic (WHHL) rabbits.
    Suzuki H; Kobayashi H; Sato F; Yonemitsu Y; Nakashima Y; Sueishi K
    J Atheroscler Thromb; 2003; 10(2):109-16. PubMed ID: 12740485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pitavastatin: an overview.
    Saito Y
    Atheroscler Suppl; 2011 Nov; 12(3):271-6. PubMed ID: 22152281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stabilization of atherosclerotic plaque by pitavastatin in Watanabe heritable hyperlipidemic rabbits: A serial tissue-characterizing intravascular ultrasound study.
    Haruta H; Hiro T; Mitsumata M; Takayama T; Sudo M; Li Y; Takahashi R; Taniguchi Y; Shiomi M; Hirayama A
    J Cardiol; 2016 Feb; 67(2):205-11. PubMed ID: 26194868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment with pitavastatin (NK-104), a new HMG-CoA reductase inhibitor, of patients with heterozygous familial hypercholesterolemia.
    Noji Y; Higashikata T; Inazu A; Nohara A; Ueda K; Miyamoto S; Kajinami K; Takegoshi T; Koizumi J; Mabuchi H;
    Atherosclerosis; 2002 Jul; 163(1):157-64. PubMed ID: 12048134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The History of the WHHL Rabbit, an Animal Model of Familial Hypercholesterolemia (II) - Contribution to the Development and Validation of the Therapeutics for Hypercholesterolemia and Atherosclerosis.
    Shiomi M
    J Atheroscler Thromb; 2020 Feb; 27(2):119-131. PubMed ID: 31748470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are all statins the same? Focus on the efficacy and tolerability of pitavastatin.
    da Silva PM
    Am J Cardiovasc Drugs; 2011; 11(2):93-107. PubMed ID: 21446776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid-lowering effects of TAK-475, a squalene synthase inhibitor, in animal models of familial hypercholesterolemia.
    Amano Y; Nishimoto T; Tozawa Ri; Ishikawa E; Imura Y; Sugiyama Y
    Eur J Pharmacol; 2003 Apr; 466(1-2):155-61. PubMed ID: 12679152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pitavastatin: efficacy and safety profiles of a novel synthetic HMG-CoA reductase inhibitor.
    Kajinami K; Takekoshi N; Saito Y
    Cardiovasc Drug Rev; 2003; 21(3):199-215. PubMed ID: 12931254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive review on the lipid and pleiotropic effects of pitavastatin.
    Sahebkar A; Kiaie N; Gorabi AM; Mannarino MR; Bianconi V; Jamialahmadi T; Pirro M; Banach M
    Prog Lipid Res; 2021 Nov; 84():101127. PubMed ID: 34509516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of pitavastatin with atorvastatin in increasing HDL-cholesterol and adiponectin in patients with dyslipidemia and coronary artery disease: the COMPACT-CAD study.
    Kurogi K; Sugiyama S; Sakamoto K; Tayama S; Nakamura S; Biwa T; Matsui K; Ogawa H;
    J Cardiol; 2013 Aug; 62(2):87-94. PubMed ID: 23672789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pitavastatin on lipid profiles and high-sensitivity CRP in Japanese subjects with hypercholesterolemia: Kansai Investigation of Statin for Hyperlipidemic Intervention in Metabolism and Endocrinology (KISHIMEN) investigatars.
    Koshiyama H; Taniguchi A; Tanaka K; Kagimoto S; Fujioka Y; Hirata K; Nakamura Y; Iwakura A; Hara K; Yamamoto T; Kuroe A; Ohya M; Fujimoto S; Hamamoto Y; Honjo S; Ikeda H; Nabe K; Tsuda K; Inagaki N; Seino Y; Kume N;
    J Atheroscler Thromb; 2008 Dec; 15(6):345-50. PubMed ID: 19075492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Widely-targeted quantitative lipidomics method by supercritical fluid chromatography triple quadrupole mass spectrometry.
    Takeda H; Izumi Y; Takahashi M; Paxton T; Tamura S; Koike T; Yu Y; Kato N; Nagase K; Shiomi M; Bamba T
    J Lipid Res; 2018 Jul; 59(7):1283-1293. PubMed ID: 29724780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel serum markers for the progression of coronary atherosclerosis in WHHLMI rabbits, an animal model of familial hypercholesterolemia.
    Shiomi M; Takeda H; Irino Y; Kimura N; Yamada S; Kuniyoshi N; Kikumori A; Koike Y; Koike T; Yoshida M; Izumi Y; Shinohara M; Bamba T; Ishida T
    Atherosclerosis; 2019 May; 284():18-23. PubMed ID: 30870703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphological features of coronary plaques in WHHLMI rabbits (Oryctolagus cuniculus), an animal model for familial hypercholesterolemia.
    Yamada S; Koike T; Nakagawa T; Kuniyoshi N; Ying Y; Itabe H; Yamashita A; Asada Y; Shiomi M
    Exp Anim; 2017 May; 66(2):145-157. PubMed ID: 28025424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.